-
Clinical features and outcomes of hypocellular acute myeloid leukemia in adults: A Korean AML registry data
IC Song, DY Jo, HJ Kim, YH Min, DS Hong, WS Lee, HJ Shin, JH Lee, ...
2021
Medicine 100 (1)
-
Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter ...
P Montesinos, GJ Roboz, CE Bulabois, M Subklewe, U Platzbecker, ...
2021
Leukemia 35 (1), 62-74
-
Prognostic Impact of Peripheral Blood T-Cell Subsets at the Time of Diagnosis on Survival in Patients with Diffuse Large B-Cell Lymphoma
HJ Shin, DY Kim, JS Chung, KH Shin, H Lee
2020
Acta Haematologica, 1-11
-
Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk
K Weisel, A Spencer, S Lentzsch, H Avet-Loiseau, TM Mark, I Spicka, ...
2020
Journal of hematology & oncology 13 (1), 1-11
-
Significant Role of Upfront Autologous Stem Cell Transplantation in Patients with High Risk Diffuse Large B-cell Lymphoma
DS Kim, SH Jung, DH Yang, Y Koh, J Hong, HY Yhim, WS Lee, YJ Lee, ...
2020
BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 512-513
-
Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a ...
GY Song, SH Jung, JJ Lee, JS Kim, CK Min, K Kim, Y Choi, HS Eom, ...
2020
Leukemia & Lymphoma 61 (11), 2714-2721
-
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone
HS Lee, K Kim, JJ Lee, SS Yoon, SM Bang, JS Kim, HS Eom, DH Yoon, ...
2020
International Journal of Hematology, 1-11
-
Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era
GY Song, SE Yoon, SJ Kim, JS Kim, Y Koh, JH Moon, SY Oh, HS Lee, ...
2020
Scientific reports 10 (1), 1-8
-
Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study
J Jung, YS Choi, JH Lee, WS Lee, S Kim, Y Park, SS Lee, YR Do, JC Jo, ...
2020
International Journal of Hematology 112, 84-95
-
Phase II study of safety and efficacy of BEB (bendamustine, etoposide, and busulfan) conditioning regimen for autologous stem cell transplantation in non-Hodgkin lymphoma
J Chung, JC Jo, SH Cho, HJ Shin
2020
Annals of hematology 99 (4), 819-828
-
Poor prognostic impact of high serum ferritin levels in patients with a lower risk of diffuse large B cell lymphoma
T Kim, JY Jeong, JC Jo, WS Lee, HJ Shin, JH Lee, HS Lee
2020
International journal of hematology 111 (4), 559-566
-
Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party ...
HS Lee, K Kim, SJ Kim, JJ Lee, I Kim, JS Kim, HS Eom, DH Yoon, C Suh, ...
2020
American journal of hematology 95 (4), 413-421
-
Long‐term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)
YR Do, JY Kwak, JA Kim, HJ Kim, JS Chung, HJ Shin, SH Kim, ...
2020
British journal of haematology 189 (2), 303-312
-
Neutropenic Enterocolitis due to Mucormycosis in a Patient with Myelodysplastic Syndrome
JW Park, JS Chung, S Lee, HJ Shin
2020
Infection & chemotherapy 52 (1), 98
-
Analysis of the Efficacy of Thalidomide Plus Dexamethasone-Based Regimens in Patients With Relapsed/Refractory Multiple Myeloma Who Received Prior Chemotherapy, Including ...
KS Jung, K Kim, HJ Kim, SH Kim, JO Lee, JS Kim, JJ Lee, HS Eom, ...
2020
Clinical Lymphoma Myeloma and Leukemia 20 (2), e97-e104
-
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean ...
JC Jo, HS Lee, K Kim, JJ Lee, SS Yoon, SM Bang, JS Kim, HS Eom, ...
2020
Annals of hematology 99 (2), 309-319
-
Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: consortium for improving survival of lymphoma report
JC Jo, SJ Kim, HS Lee, HS Eom, SI Lee, Y Park, JO Lee, Y Lee, HY Yhim, ...
2020
Annals of hematology 99 (2), 223-228
-
S-534: Age and remission induction therapy for acute myeloid leukemia (AML): from Korean AML registry
이동하,유쾌한,김형준, 민유홍, 홍대식, 이원식, 김희제, 신호진, 박용, ...
2020
대한내과학회 추계학술발표논문집 2020 (1), 577-577
-
Effect of Stem Cell Source and Dose on Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Idiopathic Aplastic Anemia: Data from the Korean Aplastic ...
H Kim, KH Lee, SK Sohn, I Kim, SH Kim, Y Park, JH Choi, JY Kwak, ...
2020
Acta haematologica 143 (3), 232-243
-
Neutropenia following intravenous immunoglobulin therapy in adult patients with immune thrombocytopenic purpura: A single center experience and literature review
SB Oh, HJ Shin
2020
Medicine 99 (1)
-
Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival
J Nam, DU Kim, E Kim, B Kwak, MJ Ko, AY Oh, BJ Park, YW Kim, AR Kim, ...
2019
Leukemia 33 (12), 2912-2923
-
Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study
SY Oh, WS Kim, JS Kim, SJ Kim, DH Yoon, DH Yang, WS Lee, HJ Kim, ...
2019
Cancer Communications 39 (1), 1-10
-
Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myeloma
YJ Lee, JH Moon, SK Sohn, SJ Kim, SH Jung, JJ Lee, JC Jo, HJ Shin, ...
2019
Bone marrow transplantation 54 (12), 2051-2059
-
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma
SJ Kim, DH Yoon, HJ Kang, JY Hong, HS Lee, SY Oh, HJ Shin, JH Kong, ...
2019
BMC cancer 19 (1), 1-7
-
Prognostic Significance of Interim PET/CT Assessment for the Treatment of Advanced Stage of Marginal Zone Lymphoma in the Post Immunochemotherapy Era
GY Song, SJ Kim, SE Yoon, JS Kim, HY Yhim, Y Koh, SY Oh, HS Lee, ...
2019
Blood, The Journal of the American Society of Hematology 134 (Supplement_1 ...
-
Open-Labeled, Multicenter Phase II Study of Bortezomib for Maintenance Therapy in Patients with High Risk Diffuse Large B Cell Lymphoma (DLBCL): Borma Trial from Consortium for ...
JC Jo, HS Lee, C Suh, HJ Kang, WS Kim, HS Eom, I Kim, HJ Shin, Y Park, ...
2019
Blood, The Journal of the American Society of Hematology 134 (Supplement_1 ...
-
Pomalidomide, Cyclophosphamide, and Dexamethasone for Elderly, Transplant-Ineligible Patients with Relapsed and/or Refractory Multiple Myeloma Who Had Failed Treatment with ...
HS Lee, CK Min, K Kim, SJ Kim, JJ Lee, I Kim, SS Yoon, JS Kim, HS Eom, ...
2019
Blood, The Journal of the American Society of Hematology 134 (Supplement_1 ...
-
BAY 94‐9027 prophylaxis is efficacious and well tolerated for up to> 5 years with extended dosing intervals: PROTECT VIII extension interim results
S Lalezari, MT Reding, I Pabinger, PA Holme, C Negrier, P Chalasani, ...
2019
Haemophilia 25 (6), 1011-1019
-
The effects of erythropoiesis‐stimulating agents on the management of chemotherapy‐induced anemia and tumor growth in diffuse large B‐cell lymphoma patients
LC Park, YJ Song, DJ Kim, MJ Kim, JC Jo, WS Lee, HJ Shin, SY Oh, ...
2019
International journal of cancer 145 (9), 2459-2467
-
Body cavity–based lymphoma in a country with low human immunodeficiency virus prevalence: a series of 17 cases from the Consortium for Improving Survival of Lymphoma
J Shin, YH Ko, SY Oh, DH Yoon, JO Lee, JS Kim, Y Park, HJ Shin, SJ Kim, ...
2019
Cancer research and treatment: official journal of Korean Cancer Association ...
-
Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome
H Kim, JH Lee, WS Lee, I Kim, JH Moon, CW Choi, HS Lee, J Park, Y Choi, ...
2019
British journal of haematology 186 (5), e151-e155
-
Favorable Outcomes With Tumor Burden Reduction Following Administration of Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Patients With Higher ...
S Park, DW Baek, SK Sohn, JS Ahn, HJ Kim, HJ Shin, JS Chung, SM Lee, ...
2019
Clinical Lymphoma Myeloma and Leukemia 19 (7), e367-e373
-
Different prognostic effects of core-binding factor positive AML with Korean AML registry data
HJ Shin, WS Min, YH Min, JW Cheong, JH Lee, IH Kim, DS Hong, JS Ahn, ...
2019
Annals of hematology 98 (5), 1135-1147
-
HMG CoA reductase expression as a prognostic factor in Korean patients with breast cancer: A retrospective study
H Kim, YM Seol, YJ Choi, HJ Shin, JS Chung, N Shin, A Kim, JY Kim, ...
2019
Medicine 98 (13)
-
T-Cell Receptor Rearrangements Determined Using Fragment Analysis in Patients With T-Acute Lymphoblastic Leukemia
H Kim, IS Kim, CL Chang, SY Kong, YT Lim, SG Kong, EH Cho, EY Lee, ...
2019
Annals of laboratory medicine 39 (2), 125
-
Multicenter Phase 2 Study of Reduced-Dose CHOP Chemotherapy Combined With Rituximab for Elderly Patients With Diffuse Large B-Cell Lymphoma
S Park, JC Jo, YR Do, DH Yang, SN Lim, WS Lee, WS Kim, HS Lee, ...
2019
Clinical Lymphoma Myeloma and Leukemia 19 (3), 149-156
-
Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL ...
SH Jung, S Lee, DH Yang, S Lee, JH Yoon, H Lee, SM Bang, Y Koh, ...
2019
Annals of hematology 98 (1), 151-158
-
A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score
HY Yhim, Y Park, YH Han, S Kim, SR Kang, JH Moon, JH Jeong, HJ Shin, ...
2018
European journal of nuclear medicine and molecular imaging 45 (13), 2274-2284
-
Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR
A Spencer, S Lentzsch, K Weisel, H Avet-Loiseau, TM Mark, I Spicka, ...
2018
Haematologica 103 (12), 2079
-
Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts
DW Baek, YJ Lee, H Kim, SY Ahn, JS Ahn, HJ Shin, WS Lee, SM Lee, ...
2018
Annals of hematology 97 (12), 2309-2317
-
Correction to: a risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score
HY Yhim, Y Park, YH Han, S Kim, SR Kang, JH Moon, JH Jeong, HJ Shin, ...
2018
European journal of nuclear medicine and molecular imaging 45 (13), 2482-2483
-
Comparison of Prognostic Stratification between IPI, PIT, and NCCN-IPI in the Treatment of Nodal Peripheral T-Cell Lymphomas
HY Yhim, Y Park, JH Moon, HJ Shin, YS Choi, MK Kim, DS Kim, JH Lee, ...
2018
Blood 132 (Supplement 1), 1657-1657
-
Efficacy of daratumumab in combination with standard of care regimens in lenalidomide-exposed or-refractory patients with relapsed/refractory multiple myeloma (RRMM): analysis ...
SZ Usmani, MV Mateos, S Lentzsch, H Quach, M Capra, R Ovilla, JC Jo, ...
2018
Blood 132 (Supplement 1), 3288-3288
-
Final Study Results of Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 48 Months Follow-up
YR Do, JY Kwak, H Kim, JA Kim, HJ Kim, JS Park, J Chung, HJ Shin, ...
2018
Blood 132 (Supplement 1), 1733-1733
-
No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome
SK Sohn, JH Moon, IH Lee, JS Ahn, HJ Kim, JS Chung, HJ Shin, SW Park, ...
2018
The Korean journal of internal medicine 33 (6), 1194
-
Phase 2 study of an intravenous busulfan and melphalan conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma (KMM150)
SH Jung, JJ Lee, JS Kim, CK Min, K Kim, Y Choi, HS Eom, YD Joo, ...
2018
Biology of Blood and Marrow Transplantation 24 (5), 923-929
-
Sat-363: ESHAP with Roflumilast as second-line chemotherapy for refractory or relapsed DLBCL
김철식, 신호진, 김도영
2018
대한내과학회 추계학술발표논문집 2018 (1), 237-237
-
The derived neutrophil-to-lymphocyte ratio is an independent prognostic factor in transplantation ineligible patients with multiple myeloma
GW Lee, SW Park, SI Go, HG Kim, MK Kim, CK Min, JY Kwak, SB Bae, ...
2018
Acta haematologica 140 (3), 146-156
-
the Safety and Efficacy of Pomalidomide in Combination with Cyclophosphamide and Dexamethasone (PCD) in the Transplant-Ineligible Patients with Relapsed and/or Refractory ...
HS Lee, CK Min, K Kim, SJ Kim, JJ Lee, I Kim, JS Kim, HS Eom, DH Yoon, ...
2017
Blood 130 (Supplement 1), 1834-1834
-
The Clinical Outcomes of Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: A Nationwide Registry Study of the Korean Multiple Myeloma ...
HS Lee, CK Min, JJ Lee, K Kim, SS Yoon, I Kim, SM Bang, JS Kim, ...
2017
Blood 130 (Supplement 1), 3130-3130
-
Deeper molecular response in patients (PTS) with newly diagnosed chronic myeloid leukemia chronic phase (CML-CP) patients receiving radotinib 300 Mg BID or Imatinib: Rerise 36 ...
YR Do, H Kim, JY Kwak, JA Kim, HJ Kim, JS Park, J Chung, HJ Shin, ...
2017
Blood 130 (Supplement 1), 317-317
-
Phase III clinical trial (RERISE study) results of efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia
JY Kwak, SH Kim, SJ Oh, DY Zang, H Kim, JA Kim, YR Do, HJ Kim, ...
2017
Clinical Cancer Research 23 (23), 7180-7188
-
Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy
H Cho, DH Yoon, JB Lee, SY Kim, JH Moon, YR Do, JH Lee, Y Park, ...
2017
American journal of hematology 92 (12), 1280-1286
-
Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy
SB Oh, SW Park, JS Chung, WS Lee, HS Lee, SH Cho, YS Choi, SN Lim, ...
2017
Annals of hematology 96 (11), 1801-1809
-
The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160)
SH Jung, JJ Lee, K Kim, C Suh, DH Yoon, CK Min, SK Sohn, CW Choi, ...
2017
Oncotarget 8 (45), 79517
-
A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell ...
MK Kim, K Kim, CK Min, JY Kwak, SB Bae, SS Yoon, JJ Lee, KH Kim, ...
2017
Oncotarget 8 (23), 37605
-
Safety and efficacy of BAY 94‐9027, a prolonged‐half‐life factor VIII
MT Reding, HJ Ng, LH Poulsen, ME Eyster, I Pabinger, HJ Shin, R Walsch, ...
2017
Journal of Thrombosis and Haemostasis 15 (3), 411-419
-
Daratumumab, Bortezomib and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in RRMM Based on Prior Lines and Treatment Exposure: CASTOR
S Lentzsch, A Nooka, H Quach, C Lee, W Barreto, P Corradini, CK Min, ...
2017
Clinical Lymphoma, Myeloma and Leukemia 17 (1), e133
-
Phase 2 Study Using Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma; Final Analysis (KMM150)
JJ Lee, SH Jung, K Kim, JS Kim, HS Eom, CK Min, JH Moon, SK Sohn, ...
2017
Clinical Lymphoma, Myeloma and Leukemia 17 (1), e73-e74
-
S-586: Negative impact of malnutrition & cardiovascular risk factors on DLBCL patients with rituximab
김희진, 오성용, 이지현, 이호섭, 조재철, 최윤석, 이원식, 권경아, ...
2017
대한내과학회 추계학술발표논문집 2017 (1), 336-336
-
S-572: Multiple Simultaneous Arterial Infarction in a Multiple Myeloma Patient Undergoing Hemodialysis
강진숙, 송상헌, 성은영, 곽임수, 이하린, 신호진, 이선희, 이신원, ...
2017
대한내과학회 추계학술발표논문집 2017 (1), 329-329
-
S-585: Modified-IPI by inflammatory factor-based scoring system in DLBCL patients receiving Rituximab
김희진, 오성용, 이지현, 조재철, 최윤석, 신호진, 이원식, 권경아, ...
2017
대한내과학회 추계학술발표논문집 2017 (1), 336-336
-
S-563: Hemoblobin and Serum Ferritin level as Prognostic Factor in DLBCL
김태윤, 이호섭, 정지영, 조재철, 이원식, 신호진, 이지현
2017
대한내과학회 추계학술발표논문집 2017 (1), 325-325
-
Phase II Trial of R-CVP Followed By Rituximab Maintenance Therapy for Patients with Advanced Stage Marginal Zone Lymphoma-Consortium for Improving Survival of Lymphoma (CISL) Study
SY Oh, WS Kim, JS Kim, SJ Kim, S Lee, DH Yoon, DH Yang, WS Lee, ...
2016
Blood, The Journal of the American Society of Hematology 128 (22), 1811-1811
-
Prospective, Non-Randomized, Open-Label, Single-Arm, Multi-Center Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Immunoglobulin 10% Formulation in Patients ...
SM Bang, YC Mun, HJ Shin, CW Jung, SH Bae, SK Sohn, KH Kim, H Kim, ...
2016
Blood, The Journal of the American Society of Hematology 128 (22), 4938-4938
-
The efficacy of JAK2 inhibitor in heavily pretreated classical Hodgkin lymphoma: a prospective pilot study of ruxolitinib in relapsed or refractory classical Hodgkin lymphoma ...
SJ Kim, HJ Kang, S Dong-Yeop, HS Lee, SY Oh, HJ Shin, DH Yoon, ...
2016
Blood, The Journal of the American Society of Hematology 128 (22), 1820-1820
-
Daratumumab, bortezomib and dexamethasone versus bortezomib and dexamethasone alone for relapsed or refractory multiple myeloma based on prior treatment exposure: updated ...
AA Chanan-Khan, S Lentzsch, H Quach, N Horvath, M Capra, R Ovilla, ...
2016
Blood, The Journal of the American Society of Hematology 128 (22), 3313-3313
-
Clinical usefulness of inflammatory factors based modified international prognostic index in diffuse large B cell lymphoma treated with rituximab combined chemotherapy
C Kim, HS Lee, JC Jo, HJ Shin, SY Oh, WS Lee, J Jeong
2016
Blood, The Journal of the American Society of Hematology 128 (22), 4220-4220
-
Clinical impact of induction treatment modalities and optimal timing of radiotherapy for the treatment of limited-stage NK/T cell lymphoma
JH Moon, BH Lee, JA Kim, YJ Lee, YS Chae, HY Yhim, JY Kwak, YR Do, ...
2016
Leukemia research 49, 80-87
-
Evaluation of prognostic factors in patients with relapsed AML: Clonal evolution versus residual disease
H Kim, YM Seol, MK Song, YJ Choi, HJ Shin, SH Park, EY Lee, JS Chung
2016
Blood research 51 (3), 175
-
Cytogenetic profiles of 2806 patients with acute myeloid leukemia—a retrospective multicenter nationwide study
JM Byun, YJ Kim, HJ Yoon, SY Kim, HJ Kim, J Yoon, YH Min, JW Cheong, ...
2016
Annals of hematology 95 (8), 1223-1232
-
The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea
HS Lee, CK Min, JJ Lee, K Kim, SJ Kim, DH Yoon, HS Eom, H Lee, ...
2016
Annals of hematology 95 (6), 911-919
-
Peripheral T cell lymphomas in elderly patients: a retrospective analysis from the Hematology Association of South East Korea (HASEK)
JC Jo, Y Choi, HJ Shin, SN Yhim, HS Lee, WS Lee, JH Lee, H Kim, SY Oh
2016
Annals of hematology 95 (4), 619-624
-
Induction chemotherapy followed by up-front autologous stem cell transplantation may have a survival benefit in high-risk diffuse large B-cell lymphoma patients
HJ Shin, DH Yoon, HS Lee, SY Oh, DH Yang, HJ Kang, SY Chong, Y Park, ...
2016
Experimental hematology 44 (1), 3-13
-
Efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia patients: 12 months result of phase 3 clinical trial
JY Kwak, H Kim, JA Kim, YR Do, HJ Kim, JS Park, JS Chung, HJ Shin, ...
2015
Blood, The Journal of the American Society of Hematology 126 (23), 476-476
-
Long‐term follow‐up of imatinib plus combination chemotherapy in patients with newly diagnosed P hiladelphia chromosome‐positive acute lymphoblastic leukemia
SN Lim, YD Joo, KH Lee, DY Kim, JH Lee, JH Lee, HS Chi, SC Yun, ...
2015
American journal of hematology 90 (11), 1013-1020
-
Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma?: Consortium for Improving Survival of Lymphoma (CISL) study
MS Koh, WS Kim, SJ Kim, SY Oh, DH Yoon, SI Lee, J Hong, MK Song, ...
2015
International journal of hematology 102 (4), 420-425
-
Single monosomy as a relatively better survival factor in acute myeloid leukemia patients with monosomal karyotype
JE Jang, YH Min, J Yoon, I Kim, JH Lee, CW Jung, HJ Shin, WS Lee, ...
2015
Blood cancer journal 5 (10), e358-e358
-
The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea
C Kim, HS Lee, CK Min, JJ Lee, K Kim, DH Yoon, HS Eom, H Lee, ...
2015
The Korean journal of internal medicine 30 (5), 675
-
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia
DY Kim, YD Joo, SN Lim, SD Kim, JH Lee, JH Lee, DH Kim, K Kim, ...
2015
Blood, The Journal of the American Society of Hematology 126 (6), 746-756
-
Weekly rituximab consolidation following four cycles of R‐CHOP induction chemotherapy in very elderly patients with diffuse large B‐cell lymphoma: Consortium for improving ...
SH Jung, JJ Lee, WS Kim, WS Lee, YR Do, SY Oh, MK Kim, YC Mun, ...
2015
European journal of haematology 94 (6), 504-510
-
Maximum standardized uptake value on positron emission tomography/computed tomography predicts clinical outcome in patients with relapsed or refractory diffuse large B-cell ...
HR Jang, MK Song, JS Chung, DH Yang, JO Lee, J Hong, SH Cho, ...
2015
Blood research 50 (2), 97
-
Diffuse thyroid 18F-FDG uptake after R-CHOP therapy predicts favorable outcome in patients with DLBCL
MK Song, JS Chung, SJ Kim, SS Kim, HJ Shin
2015
Annals of hematology 94 (6), 995-1001
-
Incidences and prognostic impact of c-KIT, WT1, CEBPA, and CBL mutations, and mutations associated with epigenetic modification in core binding factor acute myeloid leukemia: a ...
SH Park, HJ Lee, IS Kim, JE Kang, EY Lee, HJ Kim, YK Kim, JH Won, ...
2015
Annals of laboratory medicine 35 (3), 288
-
The t (11 ;14)(q13; q32) translocation as a poor prognostic parameter for autologous stem cell transplantation in myeloma patients with extramedullary plasmacytoma
HJ Shin, K Kim, JJ Lee, MK Song, EY Lee, SH Park, SH Kim, MA Jang, ...
2015
Clinical Lymphoma Myeloma and Leukemia 15 (4), 227-235
-
Early intensified intravenous cyclosporine therapy predicts favorable response to immunosuppressive therapy with rabbit antithymocyte globulin in patients with severe aplastic ...
MK Song, JS Chung, YD Joo, GW Lee, J Hong, SH Park, HJ Shin
2015
Leukemia research 39 (3), 284-289
-
Incidence, clinical features, and prognostic impact of CALR exon 9 mutations in essential thrombocythemia and primary myelofibrosis: an experience of a single tertiary hospital ...
SH Park, SY Kim, SM Lee, J Yi, IS Kim, HH Kim, CL Chang, EY Lee, ...
2015
Annals of laboratory medicine 35 (2), 233
-
A Case of Essential Thrombocythemia in a Patient with Ankylosing Spondylitis Concomitantly Treated with Adalimumab
DS Lee, SG Lee, HJ Shin, SH Lee, EK Park, HJ Na, CH Park, JH Park, ...
2015
Journal of Rheumatic Diseases 22 (1), 51-55
-
Statin use has negative clinical impact on non-germinal center in patients with diffuse large B cell lymphoma in rituximab era
MK Song, JS Chung, G Lee, SH Cho, J Hong, DY Shin, HJ Shin
2015
Leukemia research 39 (2), 211-215
-
High Ki-67 expression in involved bone marrow predicts worse clinical outcome in diffuse large B cell lymphoma patients treated with R-CHOP therapy
MK Song, JS Chung, JJ Lee, DH Yang, IS Kim, DH Shin, HJ Shin
2015
International journal of hematology 101 (2), 140-147
-
Incidence and prognostic impact of DNMT3A mutations in Korean normal karyotype acute myeloid leukemia patients
SH Park, JC Choi, SY Kim, J Yi, SH Oh, IS Kim, HH Kim, CL Chang, ...
2015
BioMed research international 2015
-
Clinical efficacy of mitoxantrone and Ara-C with or without etoposide salvage chemotherapy in adult patients with relapsed or refractory acute lymphoblastic leukemia ...
JS Ahn, DH Yang, SH Jung, JJ Lee, I Kim, S Park, JS Chung, HJ Shin, ...
2015
Acta haematologica 133 (1), 91-97
-
S-421: Delirium in Patients with Cancer at a Tertiary Hospice Care Unit
YJ Park, YJ Choi, YM Seol, HJ Kim, HJ Shin, JS Chung
2015
대한내과학회 추계학술발표논문집 2015 (1), 248-248
-
Inferior long-term outcome of front-line hypomethylating agent compared to supportive care in patients with lower risk myelodysplastic syndrome: Prosensity score matched analysis
SK Sohn, JH Moon, A Jae Sook, HJ Kim, M Song, HJ Shin, WS Lee, ...
2014
Blood, The Journal of the American Society of Hematology 124 (21), 3255-3255
-
Monosomal and complex karyotypes as prognostic parameters in patients with International Prognostic Scoring System higher risk myelodysplastic syndrome treated with azacitidine
KL Hwang, MK Song, HJ Shin, HJ Na, DH Shin, JK Kim, JH Moon, JS Ahn, ...
2014
Blood research 49 (4), 234
-
Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma
HJ Shin, K Kim, JW Lee, MK Song, JJ Lee, HS Lee, WS Lee, SJ Kim, ...
2014
European journal of haematology 93 (5), 414-421
-
Busulfan-containing conditioning regimens are optimal preparative regimens for autologous stem cell transplant in patients with diffuse large B-cell lymphoma
HJ Shin, WS Lee, HS Lee, H Kim, GW Lee, MK Song, JS Kim, HY Yhim, ...
2014
Leukemia & lymphoma 55 (11), 2490-2496
-
Influence of NK cell count on the survival of patients with diffuse large B-cell lymphoma treated with R-CHOP
JK Kim, JS Chung, HJ Shin, MK Song, JW Yi, DH Shin, DS Lee, SM Baek
2014
Blood research 49 (3), 162
-
항암화학요법 유발 말초신경병증에 대한 침치료의 효과: 파일럿 연구
한창우, 황의형, 김효정, 신호진
2014
동의생리병리학회지 28 (4), 460-463
-
Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study
S Oh, DH Koo, MJ Kwon, K Kim, C Suh, CK Min, SS Yoon, HJ Shin, DY Jo, ...
2014
Annals of hematology 93 (8), 1353-1361